Patents-Review.com
ClassID:

111214 ⎘

C12N2770/16034 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Caliciviridae Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260137769
2026-05-21

NUCLEIC ACID MOLECULES AND USES THEREOF

 #2
20250269007
2025-08-28

NUCLEIC ACID MOLECULES AND USES THEREOF

 #3
20250263443
2025-08-21

RECOMBINANT ROTAVIRUS EXPRESSING EXOGENOUS PROTEIN AND USES THEREOF

 #4
20250262288
2025-08-21

Cellular Adjuvants for Viral Infection

 #5
20250197454
2025-06-19

VIRUS-LIKE PARTICLE CONTAINING CAPSID PROTEINS CONNECTED BY LINKER

 #6
20250161423
2025-05-22

SELF-ASSEMBLING PROTEIN NANOPARTICLES ENCAPSULATING IMMUNOSTIMULATORY NUCLEID ACIDS

 #7
20250082784
2025-03-13

FORMULATIONS FOR SMALL INTESTINAL DELIVERY OF RSV AND NOROVIRUS ANTIGENS

 #8
20250064915
2025-02-27

NUCLEIC ACID MOLECULES AND USES THEREOF

 #9
20250002539
2025-01-02

METHODS AND COMPOSITIONS FOR NOROVIRUS CHIMERIC THERAPEUTICS

 #10
20240376157
2024-11-14

POLYNUCLEOTIDES ENCODING NOROVIRUS VP1 ANTIGENS AND USES THEREOF

 #11
20240366754
2024-11-07

PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF VIRAL ANTIGENS AND RELATED METHODS

 #12
20240342262
2024-10-17

Cellular Adjuvants for Viral Infection

 #13
20240316176
2024-09-26

NOROVIRUS S PARTICLE BASED VACCINES AND METHODS OF MAKING AND USING SAME

 #14
20240316175
2024-09-26

Method of Conferring a Protective Immune Response to Norovirus

 #15
20240299521
2024-09-12

Cellular Adjuvants for Viral Infection

 #16
20240181033
2024-06-06

NANOGEL-COATED VACCINE

 #17
20240156942
2024-05-16

Peptide of Norovirus Origin, Polynucleotide, Antibody, Composition, Method for Identifying Neutralizing Epitope for Norovirus

 #18
20230330205
2023-10-19

NOROVIRUS VACCINE

 #19
20230293663
2023-09-21

Modified norovirus VP1 proteins and VLPS comprising modified norovirus VP1 proteins

 #20
20230192776
2023-06-22

RABBIT HAEMORRHAGIC DISEASE VIRUS (RHDV) VACCINES

 #21
20230024533
2023-01-26

Norovirus fusion proteins and VLPs comprising norovirus fusion proteins

 #22
20230015570
2023-01-19

SAPOVIRUS VACCINES

 #23
20220378944
2022-12-01

Formulations for small intestinal delivery of RSV and norovirus antigens

 #24
20220370587
2022-11-24

Cellular adjuvants for viral infection

 #25
20220152186
2022-05-19

NOROVIRUS-LIKE PARTICLES WITH IMPROVED STABILITY

 #26
20220143169
2022-05-12

Method of conferring a protective immune response to Norovirus

 #27
20210401966
2021-12-30

Compositions comprising a norovirus nucleic acid and methods of use thereof

 #28
20210371468
2021-12-02

Methods and compositions for norovirus vaccines and diagnostics

 #29
20210128714
2021-05-06

Modified norovirus VP1 proteins and VLPs comprising modified norovirus VP1 proteins

 #30
20210085778
2021-03-25

Parenteral norovirus vaccine formulations

 #31
20210000941
2021-01-07

Immunogenic composition and vaccine for generating an immune response to norovirus

 #32
20200345828
2020-11-05

Norovirus vaccine

 #33
20200345827
2020-11-05

Method of conferring a protective immune response to norovirus

 #34
20200330583
2020-10-22

Modified norovirus VP1 proteins and VLPS comprising modified norovirus VP1 proteins

 #35
20200283507
2020-09-10

Single-domain VH antibodies directed to norovirus GI.1 and GII.4 and their use

 #36
20200148725
2020-05-14

Norovirus fusion proteins and VLPS comprising norovirus fusion proteins

 #37
20200101149
2020-04-02

Cellular adjuvants for viral infection

 #38
20200069787
2020-03-05

Norovirus S particle based vaccines and methods of making and using same

 #39
20190381164
2019-12-19

Method of conferring a protective immune response to norovirus

 #40
20190282686
2019-09-19

Virus like particle purification

 #41
20190125857
2019-05-02

Artificial nucleic acid molecules encoding a norovirus antigen and uses thereof

 #42
20190125853
2019-05-02

Norovirus vaccine formulations

 #43
20180371026
2018-12-27

Feline calicivirus vaccine

 #44
20180251527
2018-09-06

Single domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use

 #45
20180185468
2018-07-05

Parenteral norovirus vaccine formulations

 #46
20180161458
2018-06-14

Formulations for small intestinal delivery of RSV and norovirus antigens

 #47
20170165356
2017-06-15

Hybrid core feline vaccines

 #48
20160317645
2016-11-03

Virus like particle purification

 #49
20160310412
2016-10-27

MICRONEEDLE

 #50
20160185826
2016-06-30

VIRUS-LIKE PARTICLE VACCINES

 #51
20160102136
2016-04-14

Single-domain VH antibodies directed to norovirus GI.1 and GII.4 and their use

 #52
20160008455
2016-01-14

Norovirus vaccine formulations

 #53
20160008451
2016-01-14

Nanoparticle-based compositions

 #54
20160000899
2016-01-07

Parenteral norovirus vaccine formulations

 #55
20150307899
2015-10-29

Baculovirus system for expressing proteins forming virus-like particles

 #56
20150023995
2015-01-22

Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

 #57
20140328873
2014-11-06

Norovirus immunogens and related materials and methods

 #58
20140286994
2014-09-25

Norovirus vaccine formulations

 #59
20140271712
2014-09-18

Methods and compositions for norovirus blockade epitopes

 #60
20140065185
2014-03-06

Mucosal immunization

 #61
20140017269
2014-01-16

Protein complex system for increased immunogenicity and functionality, and methods making and use

 #62
20130273148
2013-10-17

Norovirus vaccine formulations

 #63
20130273147
2013-10-17

Method of conferring a protective immune response to Norovirus

 #64
20130273105
2013-10-17

Norovirus vaccine formulations

 #65
20130273102
2013-10-17

Parenteral norovirus vaccine formulations

 #66
20130273090
2013-10-17

Antigen-Norovirus P-domain monomers and dimers, antigen Norovirus P-particle molecules, and methods for their making and use

 #67
20130095552
2013-04-18

Norovirus and Sapovirus antigens

 #68
20130095134
2013-04-18

Stabilized virus like particles having enhanced mucosal immunogenicity

 #69
20130052216
2013-02-28

Targeted heterologous antigen presentation on calicivirus virus-like particles

 #70
20120156243
2012-06-21

Norovirus vaccine formulations

 #71
20120141529
2012-06-07

NOROVIRUS AND SAPOVIRUS ANTIGENS

 #72
20120121710
2012-05-17

Mucosal Immunization

 #73
20120093884
2012-04-19

Norovirus capsid and rotavirus VP6 protein for use as combined vaccine

 #74
20120093861
2012-04-19

NOROVIRUS VACCINE FORMULATIONS

 #75
20120020964
2012-01-26

Antibodies for Norovirus

 #76
20110318383
2011-12-29

Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing development of calicivirus disease

 #77
20110195113
2011-08-11

Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

 #78
20110182975
2011-07-28

Method of conferring a protective immune response to norovirus

 #79
20110104192
2011-05-05

NOROVIRUS AND SAPOVIRUS ANTIGENS

 #80
20110070260
2011-03-24

Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use

 #81
20110064772
2011-03-17

Viral adjuvants

 #82
20110052619
2011-03-03

Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus

 #83
20110014652
2011-01-20

Methods for producing norovirus VLPS

 #84
20110014219
2011-01-20

Norovirus and Sapovirus antigens

 #85
20100322962
2010-12-23

Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use

 #86
20100291129
2010-11-18

Norovirus and sapovirus antigens

 #87
20100266636
2010-10-21

METHOD OF CONFERRING A PROTECTIVE IMMUNE RESPONSE TO NOROVIRUS

 #88
20100215649
2010-08-26

Antibodies for norovirus

 #89
20100150961
2010-06-17

Virus like particle purification

 #90
20100047266
2010-02-25

CHIMERIC VIRUS-LIKE PARTICLES

 #91
20100041023
2010-02-18

Inactivated FCV vaccines

 #92
20090258396
2009-10-15

Crustaceans as production systems for therapeutic proteins

 #93
20090162837
2009-06-25

Inactivated FCV vaccines

 #94
20090010998
2009-01-08

Drug-delivery patch comprising a dissolvable layer and uses thereof

 #95
20080311151
2008-12-18

Vaccine For Periodontal Disease

 #96
20080299152
2008-12-04

Norovirus vaccine formulations

 #97
20080299149
2008-12-04

Raccoon Poxvirus Expressing Genes of Feline Antigens

 #98
20080279891
2008-11-13

Viral adjuvants

 #99
20080124359
2008-05-29

Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease

 #100
20080063663
2008-03-13

Hemorrhagic feline calicivirus

 #101
20070280964
2007-12-06

Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis

 #102
20070207526
2007-09-06

Norovirus and Sapovirus antigens

 #103
20070098744
2007-05-03

Probiotic enterococci for improved immunity

 #104
20070031454
2007-02-08

Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus

 #105
20060160101
2006-07-20

Inactivated FCV vaccines

 #106
20060057159
2006-03-16

Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease

 #107
20050232948
2005-10-20

Process for making an adjuvanted vaccine comprising host albumin

 #108
20050208073
2005-09-22

Vaccine against feline calicivirus

 #109
20050152911
2005-07-14

Norovirus monoclonal antibodies and peptides

 #110
20050130127
2005-06-16

Coronavirus-like particles comprising functionally deleted genomes

 #111
20050010032
2005-01-13

Vaccine for periodontal disease